BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• HIV/AIDS Diagnostics Market to Witness an Outstanding Growth by 2027

  HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immune Deficiency Syndrome) are global health problems. As such, there is growing demand to improve the effectiveness and simplify tests for HIV diagnostics, without compromising on the patient’s quality of life.

  August 29, 2022

   · 

  9 min read
• Lidocaine Injection Market: Rise in Usage of Lidocaine Injection in Dental Care to Boost the Market

  Lidocaine is a local anesthetic medication that is used to numb an area in the body in order to reduce pain or discomfort caused by invasive medical procedures such as surgery, needle punctures, or insertion of a catheter or breathing tube.

  August 29, 2022

   · 

  5 min read
• Recbio Announces Interim results for the Fiscal Year 2022 and Company Progress

  Recbio, an innovative vaccine company, released its interim result for the fiscal year 2022 in the evening of August 25.

  August 29, 2022

   · 

  10 min read
• Business

  RaySearch Laboratories: Interim report April 1 - June 30, 2022

  RaySearch signed an agreement with Region Västerbotten to provide RayStation to Norrlands universitetssjukhus.

  August 29, 2022

   · 

  3 min read
• Drug Development

  Sirnaomics Achieves 100% Complete Response in Phase II Clinical Trial of STP705 for Treatment of Cutaneous Basal Cell Carcinoma

  Sirnaomics Ltd. announced that the cohort receiving the 180μg dose level in the Phase II clinical trial of STP705 for the treatment of cutaneous basal cell carcinoma achieved a 100% complete response, indicating the promising viability of the treatment.

  August 29, 2022

   · 

  5 min read
• Business

  Horizon Therapeutics plc Announces Plans to Expand its Development and Manufacturing Facility in Waterford, Ireland

  Horizon Therapeutics plc announced it submitted a planning application to expand its development and manufacturing facility in Waterford, Ireland to add new drug substance biologics development and manufacturing capabilities.

  August 29, 2022

   · 

  3 min read
• Alvotech Announces Corporate Sustainability Participation and Discloses ESG Data covering 2020 and 2021

  Alvotech, a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced that the Company has released data on environmental, social and governance indicators for 2020 and 2021, to provide further transparency to stakeholders.

  August 29, 2022

   · 

  9 min read
• Biotech Beach

  ONK Therapeutics Presents Promising In-Vivo Data of its Optimized Affinity CD38 CAR-NK Candidate, Being Developed for the Treatment of Multiple Myeloma

  ONK Therapeutics announced the first in-vivo data for ONKT102, a fully human, optimized affinity CD38 CAR-NK cell therapy.

  August 29, 2022

   · 

  4 min read
• Biotech Beach

  Evolus to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

  Evolus, Inc. announced that members of its management team will be participating in the H.C. Wainwright 24th Annual Global Investment Conference.

  August 29, 2022

   · 

  1 min read
• Business

  IDEAYA Announces Achievement of First Milestone in Ongoing Collaboration with GSK for Potential First-in-Class Pol Theta Helicase Inhibitor Development Candidate

  IDEAYA Biosciences, Inc. announced that it has achieved a preclinical development milestone in connection with ongoing IND-enabling studies for its Pol Theta Helicase Development Candidate.

  August 29, 2022

   · 

  4 min read